Lilly's Foundayo (Orforglipron) Weight-Loss Pill Approved by FDA
The FDA approved Eli Lilly's Foundayo, a once-daily GLP-1 pill for weight loss that needs no food or water restrictions, with direct-to-consumer sales from April 6.
1.00
Pins matching tag:Foundayo
Sort by
Filters Foundayo
Posted within All
Sort by
Lilly Breaks Ground on $6.5B Foundayo Plant in Houston's Generation Park
CONFIRMED84% CONFIDENCELilly's release is datelined "HOUSTON[4], Sept. 21, 2026" and says Lilly "broke ground today in Houston, Texas[6]"; Community Impact[2] reports the groundbreaking ceremony was held Sept. 21.
A 236-acre plant that will make the active ingredient of Lilly's Foundayo weight-loss pill, with more than 600 permanent jobs and about 4,000 construction jobs. Lilly expects it running by 2030.
$6.5B
1.00
Eli Lilly Q3 2026 Earnings Call
ESTIMATED71% CONFIDENCELilly has not confirmed the date yet (no "Lilly confirms date and conference call for third-quarter 2026" release as of 22 Sep 2026; the Q2 one came out on 22 July for 5 August). Public.com[2] and Nasdaq[3] list the Q3 report as "expected" on 10/29/2026 "before market open", matching Lilly's pattern (Q3 2025 reported October 30, 2025) and its calls, which "will begin at 10 a.m. Eastern time" - so 29 Oct 2026, 10:00 ET (14:00 UTC), estimated until Lilly's confirmation release.
Eli Lilly is expected to report third-quarter 2026 results on 29 October, with its usual 10 a.m. ET conference call. It goes in guiding to $85-87 billion of 2026 revenue after second-quarter revenue jumped 48% to $23.0 billion on Mounjaro and Zepbound.
1.00